This observational study was approved by the local institutional Research Ethics Board. Adult females were recruited from the local community into the case (those with PVD) or control (no history of gynaecologic pain) groups based on history and gynaecologic exam (Friedrich’s criteria). Exclusion criteria were pregnancy, menopause, and diagnosed gynaecologic conditions other than PVD. Participants attended one laboratory-based assessment within the first week following their menstrual period. Informed consent and demographic data were collected. After participants performed three maximum voluntary PFM contraction efforts, a custom electronic device (The VQueST) was used to apply standardized pressures to the posterior vaginal fourchette (VF) and to the posterior thigh (PT) to assess the electromyographic (EMG) responses of the PFMs to those pressures. The primary outcome was the amplitude of the EMG response in the superficial (EAS, BC) and deep (PV) PFMs. Two pressures were used: low (25 grams) and moderate (232 grams), the latter based on previous research which determined that, on average, women with PVD rate this pressure as producing a pain intensity of 4 on a 10-point numerical rating scale. Five trials of each pressure level were applied to each site in a randomized order. Participants were informed about the location and intensity of the stimulus prior to its application.
To record PV muscle activation, a pair of custom suction electrodes was placed intravaginally, with the active pole on the lateral sidewall over the PV muscle and the reference pole located anteriorly over the pubis, just within the introitus to avoid crosstalk from the urethral sphincters. Adhesive electrode pairs were placed on the skin over the BC and the EAS on the right side. A common reference electrode was placed over the right anterior superior iliac spine. Heart rate (HR) was recorded concurrently using electrodes placed over the 8th rib on the left side. PFM EMG and HR data were amplified (Delsys, USA) digitized (16-bit, National Instruments, USA) and sampled at 1kHz (Powerlab, AD Instruments Ltd, USA). EMG data had the DC offset removed, were full-wave rectified, then were smoothed using a 10Hz 4th order, dual-pass low-pass Butterworth filter. The mean amplitude of the smoothed EMG signal was computed over 500ms windows at baseline (lowest mean EMG amplitude between 2-4s prior to the pressure), before (500 ms prior to the pressure), during (highest mean EMG from the onset to the offset of the pressure), and after (initial 500ms after the pressure was removed) each trial. All EMG values were normalized to the average peak acquired during three maximum voluntary PFM activation efforts.
As no previous study has evaluated differences in EMG responses to pressure applied to the VF between those with and without PVD, the required sample size (80% power, α=0.05, n=38 per group) was estimated based on doubling the sample size required to observe group differences in tonic EMG activation of the BC (d= 2.95, n=5) and PV (d=0.94, n=19) muscles [2]. A 4-way repeated-measures ANOVA was used to evaluate the effect of group (control vs PVD), site (VF vs PT), intensity (low vs moderate) and phase (baseline, before, during, after) on the EMG activation amplitude recorded from each muscle group. As a secondary objective, heart rate (HR) and HR variability (HRV) were compared between groups, stimulus sites and pressure intensities to investigate potential group differences in the level of stress induced by the protocol. Tukey’s post hoc tests were used to evaluate all interactions through pairwise differences. Alpha=0.05 was used for all tests.